Bioheart , Inc.

Industry:	Medical Devices & Equipment
Revenues:	$313,000
Employees:	28

Description

BioHeart, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. The Company’s lead product candidate is MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient’s heart with autologous muscle cells, or cells from the patient’s body, for the purpose of improving cardiac function in chronic heart failure patients. The core technology used in MyoCell has been the subject of human clinical trials conducted over the last six years involving 89 enrollees and 75 treated patients. BioHeart’s clinical trials of MyoCell include the SEISMIC Trial, a completed 40 patient Phase II clinical trial in various countries in Europe, and the MYOHEART Trial, a completed 20 patient Phase I dose escalation trial in the United States.
(Source: 10-K)

View More Statistics

Site Statistics

Monthly Unique Visitors:	697
Site Rank:	1,494,866
Trust Rating:	Neutral
Stats by

News Archive

Bioheart, Inc. Announces Receipt of $2.8 Million in Proceeds From Pipe Financing. PR Newswire; 7/9/2009 ...July 9 /PRNewswire-FirstCall/ -- Bioheart, Inc. (OTC Bulletin Board: BHRT...2008, and through July 7, 2009, Bioheart, Inc. (the "Company") has received...common stock comprising the unit. About Bioheart, Inc. Bioheart, Inc. (BULLETIN BOARD... ...more

Bioheart Touts Breakthrough in Cardiovascular Therapy with Stem Cells Obtained from Fat Tissue. Health & Beauty Close-Up; 10/6/2009 Bioheart, Inc. said that it offers yet another...vessels, the Company noted in a release. Bioheart, in collaboration with Hospital de Clinicas...obtaining stem cells. Dr. Karl Groth, Bioheart's Chairman and CEO said on the therapy... ...more

Bioheart Makes Breakthrough in Cardiovascular Therapy with Stem Cells Obtained from Fat Tissue. Angiogenesis Weekly; 10/16/2009 Bioheart, Inc. (OTCBB:BHRT) offers yet another medical breakthrough...promote angiogenesis or formation of new blood vessels (see also Bioheart, Inc.). Bioheart, in collaboration with Hospital de Clinicas Caracas in Caracas... ...more